ArticleMedicine2019

Clinical characterization of icotinib-induced chemoresistance in erlotinib-treated lung adenocarcinoma patient with EGFR mutations: A case report.

Ka Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.